A rapid and sensitive LC–MS/MS method for quantifying oxycodone, noroxycodone, oxymorphone and noroxymorphone in human plasma to support pharmacokinetic drug interaction studies of oxycodone
Biomedical Chromatography · 2024-07 · 38 (7)
DOI: 10.1002/bmc.5874 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 08.04.2024. Verfasst von Lotte M G Hulskotte und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Deventer Teaching Hospital, Deventer, The Netherlands. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Oxycodone. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
A sensitive and reliable LC–MS/MS method was developed and validated for the quantification of oxycodone and metabolites in human plasma. The method has a runtime of 6 min and a sensitivity of 0.1 μg/L for all analytes. Sample preparation consisted of protein precipitation. Separation was performed on a Kinetix biphenyl column (2.1 × 100 mm, 1.7 μm), using ammonium formate 5 m m in 0.1% aqueous formic acid and methanol LC–MS grade 100% in gradient elution at a flow rate of 0.4 ml/min. Detection was performed in multiple reaction monitoring mode using positive electrospray ionization. The method was linear over the calibration range of 0.1–25.0 μg/L for oxycodone, noroxycodone and noroxymorphone and 0.1–5.0 μg/L for oxymorphone. The method demonstrated good performance in terms of intra‐ and interday accuracy (86.5–110.3%) and precision (CV 1.7–9.3%). The criteria for the matrix effect were met (CV < 15%) except for noroxymorphone, for which an additional method was applied to compensate for the matrix effect. Whole blood samples were stable for 4 h at room temperature. Plasma samples were stable for 24 h at room temperature and 3 months at −20°C. Furthermore, the method was successfully applied in a pharmacokinetic drug interaction study of oxycodone and enzalutamide in patients with prostate cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Deventer Teaching Hospital, Deventer, The Netherlands.
- Unit of PharmacoTherapy, -Epidemiology & -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.
ORCID-Profile: Lotte M G Hulskotte
Zitieren
APA
Hulskotte, L. M. G., Wilbrink-Pijffers, I., Arbouw, M. E. L., Benoist, G. E., Jansman, F. G. A., & van Berlo-van de Laar, I. R. F. (2024). A rapid and sensitive LC–MS/MS method for quantifying oxycodone, noroxycodone, oxymorphone and noroxymorphone in human plasma to support pharmacokinetic drug interaction studies of oxycodone. Biomedical Chromatography, 38(7). https://doi.org/10.1002/bmc.5874
Vancouver
Hulskotte LMG, Wilbrink-Pijffers I, Arbouw MEL, Benoist GE, Jansman FGA, van Berlo-van de Laar IRF. A rapid and sensitive LC–MS/MS method for quantifying oxycodone, noroxycodone, oxymorphone and noroxymorphone in human plasma to support pharmacokinetic drug interaction studies of oxycodone. Biomedical Chromatography. 2024;38(7). doi:10.1002/bmc.5874
BibTeX
@article{Hulskotte2024,
author = {Hulskotte, Lotte M G and Wilbrink-Pijffers, Inge and Arbouw, Maurits E L and Benoist, Guillemette E and Jansman, Frank G A and van Berlo-van de Laar, Inge R F},
title = {A rapid and sensitive LC–MS/MS method for quantifying oxycodone, noroxycodone, oxymorphone and noroxymorphone in human plasma to support pharmacokinetic drug interaction studies of oxycodone},
journal = {Biomedical Chromatography},
year = {2024},
volume = {38},
number = {7},
doi = {10.1002/bmc.5874}
}
EUVIMED